Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
Dianthus Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 11, 2024
Dianthus Therapeutics reported fiscal year 2023 executive compensation information on April 11, 2024.
In 2023, seven executives at Dianthus Therapeutics received on average a compensation package of $884K, a 29% decrease compared to previous year.
Average pay of disclosed executives at Dianthus Therapeutics
Stephen Mahoney, Former President, Chief Financial and Operating Officer, received $1.7M in total, which increased by 48% compared to 2022.
Thomas Beetham, Chief Legal Officer, received a compensation package of $1.6M. 43% of the compensation package, or $673K, was in other compensation.
Lisa Olson, Chief Scientific Officer, earned $1.1M in 2023, a 15% increase compared to previous year.
Jason Gardner, Chief Executive Officer, received $668K in 2023, which decreases by 60% compared to 2022.
Marino Garcia, Chief Executive Officer, earned $496K in 2023.
Simrat Randhawa, Chief Medical Officer, received $338K in 2023.
Ryan Savitz, Chief Financial Officer, earned $330K in 2023.
Related executives
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
Ryan Savitz
Dianthus Therapeutics
Chief Financial Officer
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
You may also like
Source: SEC filing on April 11, 2024.